Today, we’re going on a journey to explore the estimated Novavax Stock Forecast for the years 2023 to 2050. We will use our Research and the company’s growth prospects to make a prediction. By the end of our journey, you will have a better understanding of the expected Novavax Stock Forecast.
Novavax is a biotechnology company that focuses on developing innovative vaccines to protect against serious infectious diseases. The company was founded in 1987 and is headquartered in Gaithersburg, Maryland, United States. Novavax offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response.
Novavax’s mission is to promote improved health by discovering, developing, and commercializing transformational vaccines to prevent serious infectious diseases. The company’s vaccine platform is designed to stimulate the immune system more effectively than traditional vaccine approaches.
Novavax’s patented Matrix-M adjuvant is a key component of its vaccine platform, which enhances the immune response to the vaccine. The company is committed to addressing some of the world’s most pressing infectious diseases, including COVID-19, influenza, and respiratory syncytial virus (RSV).
Overview of Novavax
| Name | Novavax |
| Symbol | NVAX |
| Industry | Biotechnology |
| Founded | 1987 |
| CEO | Stanley C. Erck |
| Headquarters | Gaithersburg, Maryland, United States |
| Country | United States |
| Locations | Multiple locations in the United States and Europe |
| Website | novavax.com |
| Profile | Novavax |
We will analyze the performance of the company’s stocks in recent times and provide you with a well-researched Novavax Stock Forecast for 2023, 2025, 2030 to 2050. Additionally, we will also take into analyst recommendations from various brokerage firms, including target high price, target low price, mean recommendation, and key recommendation.
Keep an eye on Novavax’s share price today with real-time updates, and examine its performance on the stock market through comprehensive charts that display the fluctuations in Novavax’s share price.
Novavax Stock Price Live
Fundamentals of Novavax
The fundamental analysis of Novavax Limited focuses on key factors to better understand the company’s valuation.
Novavax Stock Price History
Analyst Recommendations
Daily Low / High
| Telegram Channel | 👉 Click Here 🎯 |
| Facebook Page | 👉 Click Here 🎯 |
Novavax Stock Forecast 2023 to 2050
We will analyze the performance of the company’s shares in recent times and provide you with a well-researched Novavax Stock Forecast for 2023, 2025 to 2030, based on our Research knowledge and forecasting.
Novavax Stock Forecast 2023
Novavax has recently announced its updated financial guidance, which expects total revenue of $1.3 – $1.5 billion for the year. This is a positive sign for investors, as it indicates that the company is on track to achieve its financial objectives. Additionally, Novavax has successfully executed strategic partnerships and has initiated FDA submission for approval of their updated XBB COVID vaccine for the 2023 fall vaccination season.
Based on these factors, I predict that by the end of 2023, Novavax’s stock price will reach a minimum target of $15 USD and a maximum target of $20 USD. This is due to the company’s strong financial guidance and positive operational highlights, which suggest that Novavax is well-positioned for growth in the coming year.
Furthermore, Novavax’s pipeline vaccine candidates, including their CIC investigational vaccine candidate and influenza vaccine candidate, have the potential to drive further growth and revenue in the future. If these candidates are approved and successfully distributed, it could lead to even greater growth in the company’s stock price.
Novavax Stock Forecast 2024
By the end of 2024, I predict that Novavax’s stock price will reach a minimum target of $30 USD and a maximum target of $40 USD. This is based on the company’s continued growth in revenue and product sales, as well as the potential approval and distribution of their CIC investigational vaccine candidate and influenza vaccine candidate.
Novavax Stock Forecast 2025
By the end of 2025, I predict that Novavax’s stock price will reach a minimum target of $50 USD and a maximum target of $60 USD. This is based on the company’s continued success in product development and sales, as well as potential expansion into new markets and partnerships.
Novavax Stock Forecast 2027
By the end of 2027, I predict that Novavax’s stock price will reach a minimum target of $90 USD and a maximum target of $100 USD. This is based on the company’s potential for continued success in product development and sales, as well as potential expansion into new markets and partnerships.
Novavax Stock Forecast 2030
By the end of 2030, I predict that Novavax’s stock price will reach a minimum target of $150 USD and a maximum target of $200 USD. This is based on the company’s potential for continued growth and expansion, as well as the potential approval and distribution of its pipeline vaccine candidates, including its RSV vaccine candidate and its COVID-19 vaccine booster.
Novavax Stock Forecast 2040
By the end of 2040, I predict that Novavax’s stock price will reach a minimum target of $500 USD and a maximum target of $600 USD. This is based on the company’s potential for continued growth and expansion, as well as the potential approval and distribution of its pipeline vaccine candidates, including its COVID-19 vaccine booster and its universal influenza vaccine candidate.
Novavax Stock Forecast 2050
By the end of 2050, I predict that Novavax’s stock price will reach a minimum target of $1000 USD and a maximum target of $1200 USD. This is based on the company’s potential for continued success in product development and sales, as well as potential expansion into new markets and partnerships.
Novavax Stock Forecast 2023 to 2050
| Year | Minimum Target Price ($ USD) | Maximum Target Price ($ USD) |
|---|---|---|
| 2023 | $15 | $20 |
| 2024 | $30 | $40 |
| 2025 | $50 | $60 |
| 2026 | $70 | $80 |
| 2027 | $90 | $100 |
| 2030 | $150 | $200 |
| 2035 | $300 | $400 |
| 2040 | $500 | $600 |
| 2050 | $1000 | $1200 |
Novavax Stock Price in 1995?
– According to Google historical data, the price of Novavax on 8 Dec 1995 was $82.60 USD.
What is the Current Novavax Stock Price?
– As of 15 August 2023, the current stock price of Novavax is $7.24 USD Check out today’s current stock price.
Novavax Stock Forecast 2023?
– Based on our analysis, the maximum Novavax Stock Forecast in 2023 could be $20 USD.
To stay updated with the latest information related to the stock market and receive live stock market updates, follow Stockdhan and stay connected with us.
I would like to remind you that I am not authorized by SEC to provide any financial advice or recommendations. As you know, Stock price prediction is not an exact science, That’s why I am conducting in-depth research and using different AI tools to predict share prices. My purpose is only educational, and I am using AI to see what the future of the stock might look like.
Disclaimer– That these Stock Price Targets for “Novavax Stock Forecast” is only provided for informational purposes only. It does not constitute a recommendation to buy, sell or hold Novavax stock. Investors should conduct their own research and analysis and consult with financial experts before making any investment decisions— Sharedhan.com
